Md Samiul Islam | Pharmacology, Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Md Samiul Islam
Kyushu University, Japan

Md Samiul Islam
Affiliation Kyushu University
Country Japan
Scopus ID 57713850900
Documents 8
Citations 70
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event Global Innovation Technologist Awards

The Innovative Research Award recognition highlights the scholarly contributions of Md Samiul Islam, a researcher affiliated with Kyushu University, Japan. His research activities are associated with the fields of pharmacology, toxicology, pharmaceutical sciences, biotechnology, and molecular engineering. Through peer-reviewed publications and interdisciplinary scientific investigations, he has contributed to advancing knowledge in biomolecular interactions and peptide engineering. His publication record, citation performance, and emerging research influence demonstrate active participation in contemporary scientific research and innovation.[1]

Abstract

Md Samiul Islam has contributed to research involving biomolecular recognition, peptide development, and pharmaceutical sciences. His scientific output includes studies focused on protein-binding mechanisms and recombinant protein technologies. The research portfolio reflects an interdisciplinary approach combining biotechnology, molecular biology, and applied pharmaceutical sciences. These contributions support ongoing advancements in targeted therapeutic development and molecular engineering methodologies.[2]

Keywords

Peptide Engineering, Recombinant Proteins, Molecular Recognition, Pharmacology, Biotechnology, Drug Discovery, Pharmaceutical Science, Protein Binding.

Introduction

Modern pharmaceutical and biomedical research increasingly depends on understanding molecular interactions and designing biologically active compounds. Researchers working in these areas contribute to the development of innovative diagnostic and therapeutic strategies. Md Samiul Islam’s work aligns with these objectives through investigations involving peptide selection technologies and biomolecular targeting systems.[3]

Research Profile

According to indexed academic records, Md Samiul Islam has authored multiple scholarly publications and achieved measurable citation impact. His research activities are associated with Kyushu University and focus on pharmaceutical science, biotechnology, and molecular engineering. His publication metrics include 8 indexed documents, 70 citations, and an h-index of 6, reflecting recognized engagement within the scientific community.[1]

Research Contributions

  • Research on peptide discovery and molecular binding technologies.
  • Contributions to recombinant protein-based screening approaches.
  • Interdisciplinary studies connecting biotechnology and pharmaceutical sciences.
  • Support for emerging therapeutic and diagnostic innovation.

Publications

A notable publication is Directed evolution of Clec12a-binding peptides using mammalian-expressed recombinant protein, published in Biochemistry and Biophysics Reports (2026). The study explores peptide evolution and molecular binding strategies relevant to biomedical applications and protein-targeting research.[4]

Research Impact

The citation profile and publication record indicate that the research outputs have received scholarly attention. Work involving molecular recognition and peptide engineering contributes to broader scientific discussions related to biotechnology and pharmaceutical innovation. Such contributions support evidence-based advancement within the biomedical sciences.[5]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating meaningful scientific contributions and emerging research impact. Based on documented publication activity, citation performance, and contributions to pharmaceutical and biotechnology research, Md Samiul Islam represents a suitable candidate for recognition within the Global Innovation Technologist Awards framework.[6]

Conclusion

Md Samiul Islam’s research activities demonstrate engagement in contemporary pharmaceutical and biotechnology investigations. Through publications, citation impact, and interdisciplinary scientific work, he contributes to the advancement of molecular engineering and biomedical research. His scholarly profile reflects ongoing participation in scientific innovation and knowledge development within his field.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Md Samiul Islam, Author ID 57713850900. Scopus.
    https://www.scopus.com/pages/authors/57713850900
  2. Kyushu University. (n.d.). Research activities and scientific publications.
  3. Biotechnology and pharmaceutical science literature concerning molecular recognition systems.
  4. Kawaguchi, Y., Islam, M.S., Yokoyama, M., Kamiya, N., & Goto, M. (2026). Directed evolution of Clec12a-binding peptides using mammalian-expressed recombinant protein. Biochemistry and Biophysics Reports.
    https://doi.org/10.1016/j.bbrep.2026.101900
  5. Elsevier. (n.d.). Scopus citation metrics and scholarly impact indicators.
  6. Global Innovation Technologist Awards. (n.d.). Award evaluation and recognition framework.
    innovationtechnologist.com

Huawei Zhang | Natural Product Chemistry | Best Researcher Award

Published on by Innovation Technologist

Prof. Dr. Huawei Zhang | Natural Product Chemistry | Best Researcher Award

Professor at Zhejiang University of Technology, China

Dr. Huawei Zhang is a Professor of Microbe Natural Products Chemistry at the School of Pharmaceutical Sciences, Zhejiang University of Technology, China. His research primarily focuses on discovering novel marine microbe-derived biomolecules with therapeutic potential. Over his career, he has published more than 120 peer-reviewed articles with over 4000 citations and holds more than 20 patents in China and the US. His contributions to the field have earned him recognition as one of the World’s Top 2% Scientists in Medicinal & Biomolecular Chemistry from 2021 to 2024.

Publication Profile 

Scopus

Orcid

Educational Background 🎓

  • B.Sc. in Food Sciences – Northwest A&F University, China (2000)
  • M.Sc. in Food Chemistry – Northwest A&F University, China (2003)
  • Ph.D. in Natural Products Chemistry – Nanjing University, China (2006)

Professional Experience 💼

  • Postdoctoral Fellow, Nanjing University, China (2006–2008)
  • Faculty Member, Zhejiang University of Technology, China (Since April 2008)
  • Visiting Scholar, Crews Lab, University of California, Santa Cruz, USA (One year)
  • Officer on Secondment, National Center of Science & Technology Talents, China (Aug 2015 – Feb 2017)
  • Editorial Board Member, Marine Drugs, BMC Microbiology, Current Organic Chemistry
  • Professional Committee Member, China Medicinal Fungus Society, China Pharmacology Society

Research Interests 🔬

Dr. Zhang’s research revolves around marine microbial secondary metabolites, including their isolation, structure elucidation, biosynthesis, and therapeutic applications. His primary interests include:

  • Marine Microbe-Derived Natural Products
  • Secondary Metabolites and Biosynthesis Pathways
  • Antibiotic and Cytotoxic Compounds from Marine Microbes
  • Structure Elucidation of Bioactive Compounds

Awards and Honors🏆✨

  • Named in the World’s Top 2% Scientists List in Medicinal & Biomolecular Chemistry (2021–2024)
  • Holds 20+ Chinese and US Patents for microbial-derived bioactive compounds
  • Published 120+ peer-reviewed articles with over 4000 citations

Conclusion🌟

Dr. Huawei Zhang is a leading scientist in the field of natural products chemistry, particularly in marine microbial secondary metabolites. His extensive research contributions, numerous publications, and patented discoveries have significantly advanced drug discovery and biosynthetic studies. Through his academic and industrial collaborations, he continues to explore novel bioactive compounds with promising therapeutic applications.

Publications 📚

📄 Article
🧪 Single-crystal structure, Hirshfeld surface and DFT analyses of chrysomycin A, a marine microbe-derived promising agent for anticancer and antimicrobial therapy
✍️ Z. Cai, Zhehui; Z. Hu, Zhe; X. Yao, Xiaojun; P. Liang, Pengyu; H. Zhang, Huawei
📚 Journal of Molecular Structure, 2025
🔗 Citations: 0

📄 Article
💊 Enhancing transdermal delivery of chrysomycin A for the treatment of cutaneous melanoma and MRSA infections using Skin-Penetrating Peptide-Functionalized deformable liposomes
✍️ Y. Cai, Yue; X. Zhang, Xinrui; W. Hu, Wentao; H. Zhang, Huawei; X. Sun, Xuanrong
📚 International Journal of Pharmaceutics, 2025
🔗 Citations: 1

📄 Article
🦠 Intracellular MRSA-targeted lipid-polymer hybrid nanoparticles for macrophage reprogramming and intracellular MRSA eradication
✍️ Y. Cai, Yue; M. Qiao, Meilin; X. Xie, Xiuzhi; H. Zhang, Huawei; X. Sun, Xuanrong
📚 Chemical Engineering Journal, 2025
🔗 Citations: 0

📄 Article
🧬 Overexpression of the Global Transcriptional Regulator LaeA Leads to Production of Cyclic Lipopeptides in Marine-Derived Aspergillus niger L14
✍️ W. Zhou, Wenjuan; M. Li, Mengshi; W. Wang, Wei; X. Bai, Xuelian; H. Zhang, Huawei
📚 Chemistry and Biodiversity, 2025
🔗 Citations: 0

📄 Article
🌿 Green and efficient extraction of an anticancer agent N-methylsansalvamide using ultrasound-assisted deep eutectic solvents from mycelia of strain Fusarium sp. R1
✍️ Y. Bai, Yifan; T. Luo, Tao; Z. Cai, Zhehui; Y. Liu, Yuanyuan; H. Zhang, Huawei
📚 Talanta, 2025
🔗 Citations: 1

📖 Open Access Article
❄️ Unveiling biosynthetic potential of an Arctic marine-derived strain Aspergillus sydowii MNP-2
✍️ Z. Fu, Zhiyang; X. Gong, Xiangzhou; Z. Hu, Zhe; B. Wei, Bin; H. Zhang, Huawei
📚 BMC Genomics, 2024
🔗 Citations: 0

📖 Open Access Article
🧪 Optimization of fermentation conditions and medium components for chrysomycin A production by Streptomyces sp. 891-B6
✍️ Z. Hu, Zhe; Q. Weng, Qiangang; Z. Cai, Zhehui; H. Zhang, Huawei
📚 BMC Microbiology, 2024
🔗 Citations: 0

📖 Open Access Review
🦠 Non-ribosomal peptide synthetase (NRPS)-encoding products and their biosynthetic logics in Fusarium
✍️ Z. Huang, Ziwei; W. Zhu, Wangjie; Y. Bai, Yifan; X. Bai, Xuelian; H. Zhang, Huawei
📚 Microbial Cell Factories, 2024
🔗 Citations: 4

📄 Open Access Article
🧠 Chrysomycin A Reshapes Metabolism and Increases Oxidative Stress to Hinder Glioblastoma Progression
✍️ D. Liu, Dongni; W. Zhang, Wenfang; W. Feng, Wandi; G. Du, Guanhua; Y. Wang, Yuehua
📚 Marine Drugs, 2024
🔗 Citations: 0

📖 Review
🧬 Transcriptional regulators of secondary metabolite biosynthesis in Streptomyces
✍️ X. Pei, Xinwei; Y. Lei, Yunyun; H. Zhang, Huawei
📚 World Journal of Microbiology and Biotechnology, 2024
🔗 Citations: 0